Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1974 Mar;71(3):867–871. doi: 10.1073/pnas.71.3.867

Effect of Transfer Factor Therapy on Mixed Lymphocyte Culture Reactivity

Bo Dupont *, Mark Ballow †, John A Hansen *, Cedric Quick †, Edmond J Yunis †, Robert A Good *
PMCID: PMC388116  PMID: 4274562

Abstract

We have studied the effect of dialyzable transfer factor therapy on three patients with immunodeficiency disease and in one patient who demonstrated no evidence of deficiency of either humoral or cellular immunity. We found evidence for nonspecificity in the effect of transfer factor on mixed lymphocyte culture reactivity. The data suggest that in patients with immunodeficiency disease a maturation of lymphocytes may lead to a generalized increased immune responsiveness. More profoundly, our data show that transfer factor may induce changes in the expression of histocompatibility determinants. We observed changes in the expression of determinants capable of stimulating in the mixed lymphocyte culture reaction as well as an increase in the capacity of lymphocytes to respond.

Keywords: immunogenetics, human histocompatibility system, immunotherapy

Full text

PDF
867

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amos D. B., Bashir H., Boyle W., MacQueen M., Tiilikainen A. A simple micro cytotoxicity test. Transplantation. 1969 Mar;7(3):220–223. doi: 10.1097/00007890-196903000-00023. [DOI] [PubMed] [Google Scholar]
  2. Dupont B., Andersen V., Hansen G. S., Svejgaard A. Abnormal mixed lymphocyte reactions in the family of a patient with severe combined immunodeficiency. Transplantation. 1972 Nov;14(5):557–563. doi: 10.1097/00007890-197211000-00005. [DOI] [PubMed] [Google Scholar]
  3. Good R. A. Transfer factor. Cell Immunol. 1972 Apr;3(4):i–iv. doi: 10.1016/0008-8749(72)90116-5. [DOI] [PubMed] [Google Scholar]
  4. LAWRENCE H. S., RAPAPORT F. T., CONVERSE J. M., TILLETT W. S. Transfer of delayed hypersensitivity to skin homografts with leukocyte extracts in man. J Clin Invest. 1960 Jan;39:185–198. doi: 10.1172/JCI104018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Lebrun A., Sasportes M., Dausset J. Role of MLC locus and related genes of the chromosomal HL-A region. Transplant Proc. 1973 Mar;5(1):363–367. [PubMed] [Google Scholar]
  6. Levin A. S., Spitler L. E., Stites D. P., Fudenberg H. H. Wiskott-Aldrich syndrome, a genetically determined cellular immunologic deficiency: clinical and laboratory responses to therapy with transfer factor. Proc Natl Acad Sci U S A. 1970 Oct;67(2):821–828. doi: 10.1073/pnas.67.2.821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Mempel W., Grosse-Wilde H., Albert E., Thierfelder S. A typical MLC reactions in HL-A-typed related and unrelated pairs. Transplant Proc. 1973 Mar;5(1):401–408. [PubMed] [Google Scholar]
  8. RAPAPORT F. T., DAUSSET J., CONVERSE J. M., LAWRENCE H. S. BIOLOGICAL AND ULTRASTRUCTURAL STUDIES OF LEUCOCYTE FRACTIONS AS TRANSPLANTATION ANTIGENS IN MAN. Transplantation. 1965 Jul;3:490–500. doi: 10.1097/00007890-196507000-00004. [DOI] [PubMed] [Google Scholar]
  9. RAPAPORT F. T., LAWRENCE H. S., MILLAR J. W., PAPPAGIANIS D., SMITH C. E. Transfer of delayed hypersensitivity to coccidioidin in man. J Immunol. 1960 Apr;84:358–367. [PubMed] [Google Scholar]
  10. Spitler L. E., Levin A. S., Stites D. P., Fudenberg H. H., Pirofsky B., August C. S., Stiehm E. R., Hitzig W. H., Gatti R. A. The Wiskott-Aldrich syndrome. Results of transfer factor therapy. J Clin Invest. 1972 Dec;51(12):3216–3224. doi: 10.1172/JCI107148. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES